Browse > Article
http://dx.doi.org/10.5953/JMJH.2012.19.3.350

Factors Affecting Bone Mineral Density of the Femur in Parkinson's Disease Patients  

Kim, Sang Hee (Dong-A University Medical Center)
Lee, Eun Nam (Department of Nursing, Dong-A University)
Park, Eun Young (Daedong College of Nursing)
Kim, Jae Woo (College of Medicine, Dong-A University)
Publication Information
Journal of muscle and joint health / v.19, no.3, 2012 , pp. 350-361 More about this Journal
Abstract
Purpose: The purpose of this study is to explore the level of bone mineral densities of the femur neck and to identify factors affecting bone mineral density of the femur in Parkinson's disease (PD) patients. Methods: Participants were 121 PD patients visiting the outpatient clinic of D University Hospital in B City. Bone mineral density was measured at the femur neck by using a dual-energy x-ray absorptiometry. The serum vitamin D level, the amounts of milk intake, caffeine intake, cigaret smoking, and alcohol consumption, and the number of steps taken daily were measured. Past and present disease history, the medication history, and duration of the disease were also collected. The level of disability was obtained by neurologists using the Hoehn and Yahr stage and the Unified Parkinson's Disease Rating Scale. Results: Among PD patients, 57% had osteopenia and 15.7% had osteoporosis. The bone mineral density of the femur was associated with weight, serum vitamin D level, age, and working status. Conclusion: The identification of weight and serum vitamin D level as important predictive factors emphasizes the importance of balanced nutrition for PD patients.
Keywords
Osteoporosis; Bone density; Parkinson disease;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Allen, S. H. (1994). Exercise considerations for postmenopausal women with osteoporosis. American College of Rheumatology, 7(4), 205-214.
2 Bezza, A., Ouzzif, Z., Naji, H., Achemlal, L., Mounach, A., Nouijiai, M., et al. (2008). Prevalence and risk factors of osteoporosis in patients with Parkinson's disease. Rheumatology International, 28(12), 1205 -1209. http://dx.doi.org/10.1007/s00296-008-0632-6   DOI
3 Bikle, D. D. (2008). Integrins, insulin like growth factors, and the skeletal response to load. Osteoporosis International, 19(3), 1237-1246. http://dx.doi.org/ 10.1007/s00198-008-0597-z   DOI   ScienceOn
4 Bloem, B. R., Grimbergen, Y. A., Cramer, M., Willemsen, M., & Zwinderman, A. H. (2001). Prospective assessment of falls in Parkinson's disease. Journal of Neurology, 248(11), 950-958.   DOI
5 Chapuy, M. C., Arlot, M. E., Duboeuf, F., Brun, J., Crouzet, B., Arnaud, S., et al. (1992). Vitamin $D_{3}$ and calcium to prevent hip fractures in the elderly women. The New England Journal of Medicine, 327, 1637-1642. http://dx.doi.org/10.1056/NEJM199212033272305   DOI   ScienceOn
6 Di Monaco, M., Vallero, F., Di Monaco, R., Tappero, R., & Cavanna, A. (2006). Bone mineral density in hip-fracture patients with Parkinson's disease: a case-control study. Archives of Physical Medicine Rehabilitation, 87, 1459-1462. http://dx.doi.org/10.1016/j.apmr.2006.07.265   DOI   ScienceOn
7 Evatt, M. L., Delong, M. R., Khazai, N., Rosen, A., Triche, S., & Tangricha, V. (2008). Prevalence of vitamin D insufficiency in patients with Parkinson's disease and Alzheimer disease. Archives of Neurology, 65, 1348-1352.   DOI   ScienceOn
8 Fahn, S., & Elton, R. L. (2000). Unified Parkinson's disease rating scale. In S. Fahn, C. D. Marsden, D. Calne, & M. Goldstein (Ed). Recent developments in Parkinson's disease.(153-163). New York: Macmillan Health Care Information.
9 Grimbergen, Y. A., Munneke, M., & Bloem, B. R. (2004). Falls in Parkinson's disease. Current Opinion in Neurology, 17(4), 405-415. http://dx.doi.org/10.1097/01.wco.0000137530.68867.93   DOI   ScienceOn
10 Fernandez, M. C., Parisi, M. S., Diaz, S. P., Mastaglia, S. R., Deferrari, J. M., Seijo, M., et al. (2009). A pilot study on the impact of body composition on bone and mineral metabolism in Parkinson's disease. Parkinsonism & Related Disorder, 13, 355-358. http://dx.doi.org/10.1016/j.parkreldis.2006.12.010   DOI   ScienceOn
11 Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression, and mortality. Neurology, 17, 427-442.   DOI
12 Invernizzi, M., Carda, S., Viscontini., G. S., & Cisari, C. (2009). Osteoporosis in Parkinson's disease. Parkinsonism & Related Disorders, 15(5), 339-346. http://dx.doi.org/10.1016/j.parkreldis.2009.02.009   DOI   ScienceOn
13 Kamanli, A., Ardicoglu, O., Ozgocmen, S., & Yoldas, T. K. (2008). Bone mineral density in patients with Parkinson's disease. Aging Clinical and Experimental Research, 20, 277-289.   DOI
14 Ishizaki, F., Harada, T., Katayama, S., Abe, H., & Nakamura, S. (1993). Relationships between osteopenia and clinical characteristics of Parkinson's disease. Movement Disorder, 8, 507-511.   DOI   ScienceOn
15 Johnell, O., Melton, L. J., Atkinson, E. J., O'Fallon, M., Kurland, L. T. (1992). Fracture risk in patient with Parkinsonism: A population-based study in Olmsted county, Minnesota. Age and Ageing, 21(1), 32-38.   DOI   ScienceOn
16 Korea Centers for Disease Control and Prevention (2007). Prevalence of Parkinson's disease. Seoul: Author.
17 Lee, S. H. (2008). Hyperhomocysteinemia due to levodopa treatment as a risk factor osteoporosis in patients with Parkinson's disease. Unpublished master thesis, Ulsan University, Ulsan.
18 Sato, Y., Kikuyama, M., & Oizumi, K. (1997). High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. American Academy Neurology, 49, 1273-1278.
19 Lorefalt, B., Ganowiak, W., Palhagen, S., Toss, G., Unosson, M., & Granerus, A, K. (2004). Factors of importance for weight loss in elderly patients with Parkinson's disease. Acta Neurologica Scandinavica, 110(3), 180-187. http://dx.doi.org/10.1111/j.1600-0404.2004.00307.x   DOI   ScienceOn
20 Sato, Y., Kaji, M., Tsuru, T., & Oizumi, K. (2001). Risk factors for hip fracture among elderly patients with Parkinson's disease. Journal of Neurology Science, 182, 89-93.   DOI   ScienceOn
21 Wood, B., & Walker, R. (2005). Osteoporosis in Parkinson's disease. Movement Disorders, 20(12), 1636-1640. http://dx.doi.org/10.1002/mds.20643   DOI   ScienceOn
22 Schneider, J. L., Fink, H. A., Ewing, S. K., Ensrud, K. E., & Cummings, S. R. (2008). The association of Parkinson's disease with bone mineral density and fracture in older women. Osteoporosis International, 19(7), 1093-1097. http://dx.doi.org/10.1007/s00198-008-0583-5   DOI   ScienceOn
23 Taggart, H., & Crawford, V. (1995). Reduced bone density of the hip in elderly patients with Parkinson's disease. Age & Ageing, 24(4), 326-328.   DOI   ScienceOn
24 Vaserman, N. (2005). Parkinson's disease and osteoporosis. Joint Bone Spine, 72(6), 484-488. http://dx.doi.org/10.1016/j.jbspin.2004.04.012   DOI   ScienceOn